We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current RHHBY market cap is 274B. The company's latest EPS is CHF and P/E is N/A.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Revenue | 58.32B | 62.8B | 63.28B | 58.72B | 60.5B |
| Operating Income | 18.54B | 18.15B | 17.44B | 15.4B | 13.42B |
| Net Income | 14.3B | 13.93B | 12.42B | 11.5B | 8.28B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Total Assets | 86.14B | 92.32B | 88.15B | 90.47B | 101.8B |
| Total Liabilities | 46.37B | 63.97B | 56.14B | 57.21B | 65.64B |
| Total Equity | 39.77B | 28.35B | 32.02B | 33.26B | 36.16B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
| Operating | 18.57B | 20.98B | 18.42B | 16.1B | 20.09B |
| Investing | -9.07B | -6.55B | -3.54B | -10.64B | -11.39B |
| Financing | -9.67B | -13.11B | -16.28B | -4.24B | -6.82B |
| Market Cap | 274B |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | 3.13% |
| Shares Outstanding | 6.36B |
| Average Volume (1 week) | 3.55M |
| Average Volume (1 Month) | 4.51M |
| 52 Week Change | 25.69% |
| 52 Week High | 43.96 |
| 52 Week Low | 29.20 |
| Spread (Intraday) | 0.71 (1.64%) |
| Company Name | Roche Holdings Ltd AG (QX) |
| Address |
grenzacherstrasse 124 basel 4070 |
| Website | https://www.roche.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
